To include your compound in the COVID-19 Resource Center, submit it here.

Commentaries

The missing dimension in COVID-19 vaccine development

While they race to create COVID-19 vaccines, governments, drug companies and the public health community must avoid a deadly mistake that has limited the effectiveness of other vaccines. From the moment a new medical product...

Industry is a white knight right now. Don’t throw it away

Biopharma is having a moment. All eyes are on drug, diagnostic and vaccine developers to get us out of this crisis and back to work. Now, companies -- individually and collectively -- must make good...

Can the economy be saved by your right to choose COVID testing?

Combined virus and antibody testing is our best opportunity to identify those who can immediately but carefully return to work, and in doing so restart the economy while minimizing the epidemic’s resurgence. We argue that...

Vaccine prospects for COVID-19: learnings from a 40-year biotech journey that’s still in progress

I have been in biotech research one way or another for over 40 years. This strange time of quarantine and self-isolation during the COVID-19 outbreak has given me time to reflect on how lessons from...

FDA’s hydroxychloroquine test

COVID-19 is testing FDA’s leadership. The agency’s performance will affect both the health of COVID-19 patients as well as public trust in the agency. One of many challenges facing FDA is whether to keep in...

Partnership offers hope for COVID drug development

As the world eyes a return to post-COVID crisis “normalcy,” a robust global recovery will depend on effective treatments and ultimately a vaccine. Yes, more than 400 research and clinical programs are already under way,...

Learning from AIDS: there’s more than one way to tame a virus

The HHS secretary promised a vaccine within two years. Anthony Fauci urged caution, telling reporters “we don’t have any idea how long it’s going to take to develop a vaccine, if indeed we will be...

How the U.K. healthcare sector is leveraging its strengths to beat COVID-19

Crisis is the mother of invention and COVID-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The U.K....

FDA is wrong on self-validation of COVID-19 tests

While the world waits for vaccines and therapies, smart use of public health measures is critical for beating COVID-19. Testing is the essential tool for guiding public health. FDA, America’s premier public health agency, contributed...

人人为我,我为人人: 协调全球监管,打赢新冠大流行这场硬仗

Publisher's note: the English language version of this article may be found here .  新冠疫情激起了全球医药产业的广泛响应, 许多公司正将其专精与技术投入其中, 开发疫苗和疗法。 然而, 在不同国家或地区的监管上, 我们还没有看到全球总协同。 相反, 许多监管上的决策只局限于不同的国家层面, 让全产业的努力显得支离破碎...

Biopharma must step up for those on the front lines of COVID-19

While not every biotech can develop countermeasures for COVID-19, nearly all can contribute by providing urgently needed resources to protect the clinicians and other essential workers holding the line against catastrophe, and by making their...

All for one, one for all: An urgent call to harmonize global drug regulation against COVID-19

The COVID-19 pandemic has spurred enormous activity in the drug industry around the world with many companies pooling their expertise and technologies to develop vaccines and treatments. However, we have no visible global coordination of...

Let’s improve molecular diagnostics reimbursement for the sake of public health

Enough is enough already. We could and should have a national system of molecular diagnostic instruments, with networked reporting, to enable the widespread practice of molecular medicine. It’s 2020, and I feel a need to...

It's high time to invest in educating patients about R&D

With clinical studies being postponed or interrupted amid a global pandemic, it might be tempting to press pause on patient engagement. That would be a mistake. Instead, drug sponsors should seize the opportunity to invest...

Our most powerful weapon to fight COVID-19 is patient involvement

The COVID-19 pandemic has catapulted the issue of the patient voice in healthcare and healthcare policy to the front of the global agenda. From social distancing, quarantines and the wearing of masks, to questions surrounding...